Table 2.
Changes in liver function tests
Placebo | Hydrogen water | |||||
---|---|---|---|---|---|---|
all (n = 25) | male (n = 17) | female (n = 8) | all (n = 25) | male (n = 16) | female (n = 9) | |
AST(IU/L) | ||||||
Week 0 | 24.8 ± 9.1 | 25.6 ± 5.7 | 23.1 ± 10.4 | 25.3 ± 6.7 | 25.9 ± 5.3 | 23.9 ± 8.3 |
Week 6 | 26.3 ± 6.7 | 26.9 ± 7.1 | 25.4 ± 6.8 | 26.8 ± 8.2 | 27.2 ± 9.9 | 26.4 ± 5.1 |
ALT(IU/L) | ||||||
Week 0 | 27.4 ± 15 | 28.1 ± 11 | 26.5 ± 17 | 26.9 ± 8.7 | 27.1 ± 6.7 | 26.7 ± 10.3 |
Week 6 | 28.8 ± 14 | 28.7 ± 16 | 27.6 ± 12 | 28.1 ± 6.5 | 28.8 ± 7.3 | 27.6 ± 9.9 |
γ-GPT(IU/L) | ||||||
Week 0 | 61.9 ± 54.3 | 62.3 ± 35.6 | 60.5 ± 64.7 | 62.3 ± 26.2 | 62.1 ± 34.8 | 62.4 ± 47.9 |
Week 6 | 62.8 ± 22.8 | 63.2 ± 16.5 | 62.7 ± 25.9 | 63.6 ± 36.2 | 63.9 ± 54.2 | 63.2 ± 27.4 |
AST(IU/L) | ||||||
Week 0 | 24.8 ± 9.1 | 25.6 ± 5.7 | 23.1 ± 10.4 | 25.3 ± 6.7 | 25.9 ± 5.3 | 23.9 ± 8.3 |
Week 6 | 26.3 ± 6.7 | 26.9 ± 7.1 | 25.4 ± 6.8 | 26.8 ± 8.2 | 27.2 ± 9.9 | 26.4 ± 5.1 |